COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. There is an important...
CDC LOCS
CDC LOCS
COLA has established this CDC Updates page so that you can quickly receive up to date information for clinical laboratories. COLA has been engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.
For past CDC LOCS updates, click here.
COVID-19 CLIA Post-Public Health Emergency Guidance
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. There is an important...
HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance
On September 9, 2022, the CDC alerted laboratories that the U.S. Department of Health and Human Services (HHS) has declared that the current circumstances justify the authorization of emergency use of in vitro diagnostics to detect and/or diagnose infection with the Monkeypox virus.
FDA Updates COVID-19 Test Policy and FAQs
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 27, 2022, the CDC alerted...
CDC Issues Select Agent Gram for Monkeypox Virus
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 15, 2022, the CDC alerted...
HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 9, 2022, the CDC alerted...
Variant Influenza Virus Infections
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 1, 2022, the CDC alerted...
Best Practices for Suspected Monkeypox Lesion Specimen Collection
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On August 30, 2022, CDC published a best...
Monkeypox Virus Testing Considerations to Prevent False Positive Test Results
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On August 23, 2022, CDC issued a recommendation to...
Stay Informed!
Stay informed about the latest regulatory announcements, upcoming events, trending accreditation news and other laboratory topics.